Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
暂无分享,去创建一个
[1] M. Bally,et al. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes. , 2001, Vaccine.
[2] M. Bally,et al. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. , 2001, Biochimica et biophysica acta.
[3] M. Bally,et al. Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. , 2001, Biochimica et biophysica acta.
[4] M. Bally,et al. Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). , 2001, Biochimica et biophysica acta.
[5] W. Oyen,et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.
[6] D. Tzemach,et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. , 1999, Bioconjugate chemistry.
[7] D. Devine,et al. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. , 1998, Archives of biochemistry and biophysics.
[8] C. Miller,et al. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.
[9] S. Lesieur,et al. New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates. , 1998, Biophysical journal.
[10] M. Bally,et al. An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin. , 1997, Journal of immunological methods.
[11] M S Newman,et al. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. , 1997, Biochimica et biophysica acta.
[12] S W Hui,et al. Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. , 1997, Biochimica et biophysica acta.
[13] M. Bally,et al. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). , 1997, The Journal of pharmacology and experimental therapeutics.
[14] John W. Park,et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.
[15] S. Hirota,et al. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. , 1996, Biochimica et biophysica acta.
[16] P. Cullis,et al. Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. , 1996, Biochemistry.
[17] D. Needham,et al. Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). , 1995, Biophysical journal.
[18] L. Huang,et al. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. , 1995, Biochimica et biophysica acta.
[19] N. Phillips,et al. Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids. , 1995, Immunology letters.
[20] John W. Park,et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Storm,et al. Immunoliposomes in vivo. , 1994, ImmunoMethods.
[22] N. Phillips,et al. Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status. , 1994, Journal of immunology.
[23] M. Woodle,et al. Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[24] A. Emili,et al. Immunogenicity of immunoliposomes. , 1991, Immunology letters.
[25] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[26] C. Leclerc,et al. Carrier-induced epitopic suppression is initiated through clonal dominance. , 1989, Journal of immunology.
[27] M. N. Jones,et al. The characterisation of liposomes with covalently attached proteins. , 1989, Biochimica et biophysica acta.
[28] L. Mayer,et al. Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.
[29] J. Owicki,et al. Interaction of antibodies with liposomes bearing fluorescent haptens. , 1984, Biochimica et biophysica acta.
[30] P. Shek,et al. Immune response mediated by liposome-associated protein antigens. III. Immunogenicity of bovine serum albumin covalently coupled to vesicle surface. , 1983, Immunology.
[31] R. Juliano,et al. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. , 1982, Biochimica et biophysica acta.
[32] M. Bally,et al. A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo , 2004, Cancer Chemotherapy and Pharmacology.
[33] J. Cohen,et al. Sterically stabilized liposomes: physical and biological properties. , 1994, Journal of drug targeting.
[34] M. Lascombe,et al. Three-dimensional structure of antibodies. , 1988, Annual review of immunology.
[35] B. Geiger,et al. Dynamics of antibody‐ and lectin‐mediated endocytosis of hapten‐containing liposomes by murine macrophages , 1981, European journal of immunology.
[36] R. Poljak,et al. Three-dimensional structure of immunoglobulins. , 1979, Annual review of biochemistry.